Guided ICBT for Adults With Tinnitus in Canada: A Randomized Controlled Trial
Launched by WESTERN UNIVERSITY, CANADA · Aug 29, 2024
Trial Information
Current as of June 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment for tinnitus, which is a condition that causes ringing or noise in the ears. The researchers want to find out if a guided online therapy called Internet-delivered Cognitive Behavioural Therapy (ICBT) can help reduce the distress that comes with tinnitus, as well as related issues like anxiety, depression, and insomnia. They will compare two versions of the therapy: a personalized approach tailored to individuals and a standard version. Participants will be adults aged 18 to 79 who have had tinnitus for more than six months and who can read and write in English.
If you qualify and decide to participate, you will follow an 8-week program consisting of 21 online modules. Each week, you will receive about 10 to 15 minutes of support from a trained guide via video chat or phone. Throughout the study, you'll complete online surveys to track your progress before, after the program, and three months later. This trial is not yet recruiting participants, but it aims to help those struggling with tinnitus and improve their overall quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. adults (18-79 years);
- • 2. diagnosed with tinnitus for more than 6 months;
- • 3. ability to read and write in English;
- • 4. cognitive capacity to consent and participate in the therapeutic process;
- • 5. able to access the technology required for the program (telephone, computer, internet);
- • 6. Canadian residents;
- • 7. A score of 25 or above on the Tinnitus Functional Index (TFI) suggesting the need for tinnitus care.
- Exclusion Criteria:
- • 1. have significant cognitive impairments that impact their ability to participate in the therapy;
- • 2. are currently involved in another psychotherapeutic intervention on a regular basis;
- • 3. present with severe mental health disorder that would be better treated in person (e.g., severe suicide ideation, severe substance abuse, recent history of psychosis, mania);
- • 4. have tinnitus as a consequence of a medical disorder, still under investigation;
- • 5. are reporting objective, pulsatile, or unilateral tinnitus, which have not been investigated medically;
- • 6. are undergoing any tinnitus therapy concurrently with partaking in this study.
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported